Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structural features, including the tert-butoxycarbonyl (Boc) protecting group and the sterically hindered aryl-substituted pyrrolidine core, make it valuable in asymmetric synthesis and medicinal chemistry for constructing complex targets with high stereochemical control. Commonly employed in research settings for designing drug candidates targeting metabolic and viral diseases.